Trials / Terminated
TerminatedNCT00790608
Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)
A Phase II Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus in MRSA Positive Ulcers
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Nitric BioTherapeutics, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine if topically applied nitric oxide gas is effective in reducing the quantity of bacteria (including MRSA)in a wound.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitric Oxide | Gaseous nitric oxide (1%), delivered for 30 minutes per day for 3 consecutive days |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-05-01
- Completion
- 2011-08-01
- First posted
- 2008-11-13
- Last updated
- 2011-11-29
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00790608. Inclusion in this directory is not an endorsement.